Results 121 to 130 of about 1,212,027 (321)

Systemic scleroderma.

open access: yesThe Medical clinics of North America, 2020
Jennyy Sun   +3 more
semanticscholar   +1 more source

Laboratory Practices for the Detection and Characterization of Cryoglobulins and Cryofibrinogen

open access: yesJournal of Clinical Laboratory Analysis, Volume 39, Issue 15, August 2025.
This study shows the importance of carrying out the search for both cryoproteins, cryoglobulins, and cryofibrinogen in cases of strong clinical suspicion of cryoproteinemia, despite their complex but not impossible detection. Use of correct procedures from the pre‐preanalytical phase up to reporting, of alternative methods such as immunotyping and the ...
Teresa Troiano   +5 more
wiley   +1 more source

Systemic sclerosis (Scleroderma) and malignancy

open access: yesJapanese Journal of Clinical Immunology, 2004
The association of malignancy with collagen diseases has been a focus of interest. Especially, relation between dermatomyositis and malignancy is well-recognized. I reviewed here about the coexistence of SSc and malignancy in literature. I would like to raise four points as characteristics of the relationship.
openaire   +4 more sources

Intestinal involvement in graft versus host disease in children: An overview by the ESPGHAN Gastroenterology Committee

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 81, Issue 2, Page 246-255, August 2025.
Abstract Graft versus host disease (GVHD) is a complication that frequently occurs after haematopoietic stem cell transplantation and concerns many children in paediatric haematology‐oncology and bone marrow transplantation departments. It can affect various organs, with the skin, gastrointestinal tract and liver being the most commonly involved.
Marina Vincent   +12 more
wiley   +1 more source

Juvenile localized scleroderma: a large retrospective cohort study from a tertiary care center

open access: yesPediatric Rheumatology Online Journal
Background Juvenile localized scleroderma is a rare pediatric inflammatory disease that primarily affects the skin and subcutaneous tissue but also has the potential to impact deeper tissues and can be associated with extracutaneous manifestations ...
Bugra Han Egeli   +8 more
doaj   +1 more source

Esophageal involvement in progressive systemic sclerosis

open access: yesAutopsy and Case Reports, 2013
Progressive systemic sclerosis (PSSc) is a chronic disease of unknown etiology characterized by progressive, abnormal accumulation of fibrous tissue in the skin and many organs.
Stephen A. Geller   +1 more
doaj   +1 more source

A Multidisciplinary Approach as a Goal for the Management of Complications in Systemic Scleroderma: A Literature Review and Case Scenario. [PDF]

open access: yesDiagnostics (Basel), 2023
Pătrîntașu DE   +7 more
europepmc   +1 more source

Mangiferin Against Respiratory Diseases: Pharmacological Targets and Prospects

open access: yesPharmacology Research &Perspectives, Volume 13, Issue 4, August 2025.
ABSTRACT Respiratory diseases are associated with high mortality worldwide. Respiratory infections can lead to the emergence of chronic respiratory diseases. Scientists are constantly striving to identify new therapies with reduced side effects.
Kazi Ahsan Ahmed   +10 more
wiley   +1 more source

Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives. [PDF]

open access: yesPediatr Rheumatol Online J, 2023
Stubbs LA   +21 more
europepmc   +1 more source

Laser therapy in superficial morphea lesions – indications, limitations and therapeutic alternatives [PDF]

open access: yes, 2020
Morphea or localized scleroderma is an uncommon autoimmune and inflammatory disease which affects patients of any age. Even if morphea lesions present systemic symptoms as myalgias or arthritis, it is distinct from systemic sclerosis because it does not ...
Ardeleanu, Valeriu   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy